Kathleen Schostack

Kathleen Schostack has a diverse work experience in the pharmaceutical industry. Kathleen served as the Vice President of Program and Alliance Management at TB Alliance, where they successfully led complex initiatives and managed collaborations with major pharmaceutical partners. Prior to that, they worked at Bayer as the Global Program Head in Oncology, providing strategic leadership for global teams in late-stage development. Kathleen also represented Bayer in joint collaboration committees and played a key role in the development of biomarker strategies. Earlier in their career, Kathleen worked at Roche Pharmaceuticals as a Project Leader, Group Director of Technical Regulatory Affairs, and Research Leader in Analytical R&D. In these roles, they demonstrated their expertise in project management, strategic planning, risk management, and regulatory affairs.

Kathleen Schostack has a Bachelor of Science (BS) degree in Medical Technology from Penn State University. Kathleen also holds a Doctor of Philosophy (PhD) degree in Analytical Chemistry and a Master of Science (MS) degree in Biochemistry, both from Stevens Institute of Technology.